Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment

K. Procházková, M. Staehler, I. Trávníček, T. Pitra, V. Eret, T. Ürge, L. Eberlová, M. Roušarová, P. Hošek, Z. Chudáček, J. Ferda, O. Hes, M. Hora,

. 2017 ; 98 (2) : 148-155. [pub] 20160930

Language English Country Switzerland

Document type Journal Article

AIM: Papillary renal cell carcinoma type 1 (pRCC1) represents the second most common type of malignant renal epithelial tumour. The origin of its characteristic appearance, its growth mechanism, and the long-term efficiency of its surgical treatment remain uncertain. Our aim was to determine typical characteristics of surgically treated pRCC1. METHODS: pRCC1 was verified in 83 of 1,629 (5.1%) kidney tumours surgically treated in the period of January 2007-January 2016. The clinical and radiological characteristics, type of surgery, histopathology results and follow up data were recorded. Spearman correlation, Kruskal-Wallis analysis of variance, Fisher's exact, and chi-square test were used to analyse appropriate variables. The overall survival rate was evaluated using the Gehan-Wilcoxon test and the Cox proportional hazards model. RESULTS: The mean tumour size was 52.0 mm (15-180); 98.8% of the tumours showed a spherical shape and in 82.1%, exophytic growth was observed. Partial nephrectomy was performed in 80.7%. A majority (81.9%) were classified as pT1. Tumours, 89.2% of them, belonged to Fuhrman grade 1 or 2. The mean follow-up was 46.8 months. The overall survival was associated with pT category (p ≤ 0.0001). CONCLUSIONS: Typical signs of pRCC1 are a spherical shape, exophytic growth and low Fuhrman's grade. More than three-fourths of pRCC1 could be treated by the nephron-sparing surgery.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017018
003      
CZ-PrNML
005      
20180523133000.0
007      
ta
008      
180515s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000448434 $2 doi
035    __
$a (PubMed)27684070
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Procházková, Kristýna $u Department of Urology, University Hospital Pilsen, Pilsen, Czech Republic.
245    10
$a Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment / $c K. Procházková, M. Staehler, I. Trávníček, T. Pitra, V. Eret, T. Ürge, L. Eberlová, M. Roušarová, P. Hošek, Z. Chudáček, J. Ferda, O. Hes, M. Hora,
520    9_
$a AIM: Papillary renal cell carcinoma type 1 (pRCC1) represents the second most common type of malignant renal epithelial tumour. The origin of its characteristic appearance, its growth mechanism, and the long-term efficiency of its surgical treatment remain uncertain. Our aim was to determine typical characteristics of surgically treated pRCC1. METHODS: pRCC1 was verified in 83 of 1,629 (5.1%) kidney tumours surgically treated in the period of January 2007-January 2016. The clinical and radiological characteristics, type of surgery, histopathology results and follow up data were recorded. Spearman correlation, Kruskal-Wallis analysis of variance, Fisher's exact, and chi-square test were used to analyse appropriate variables. The overall survival rate was evaluated using the Gehan-Wilcoxon test and the Cox proportional hazards model. RESULTS: The mean tumour size was 52.0 mm (15-180); 98.8% of the tumours showed a spherical shape and in 82.1%, exophytic growth was observed. Partial nephrectomy was performed in 80.7%. A majority (81.9%) were classified as pT1. Tumours, 89.2% of them, belonged to Fuhrman grade 1 or 2. The mean follow-up was 46.8 months. The overall survival was associated with pT category (p ≤ 0.0001). CONCLUSIONS: Typical signs of pRCC1 are a spherical shape, exophytic growth and low Fuhrman's grade. More than three-fourths of pRCC1 could be treated by the nephron-sparing surgery.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a karcinom z renálních buněk $x chirurgie $7 D002292
650    _2
$a rozdělení chí kvadrát $7 D016009
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $x patologie $7 D007668
650    _2
$a nádory ledvin $x chirurgie $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a nefrektomie $7 D009392
650    _2
$a nefrony $x chirurgie $7 D009399
650    _2
$a prognóza $7 D011379
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Staehler, Michael
700    1_
$a Trávníček, Ivan
700    1_
$a Pitra, Tomáš
700    1_
$a Eret, Viktor
700    1_
$a Ürge, Tomáš
700    1_
$a Eberlová, Lada
700    1_
$a Roušarová, Milena
700    1_
$a Hošek, Petr $7 xx0224573
700    1_
$a Chudáček, Zdeněk
700    1_
$a Ferda, Jiří
700    1_
$a Hes, Ondřej
700    1_
$a Hora, Milan
773    0_
$w MED00004616 $t Urologia internationalis $x 1423-0399 $g Roč. 98, č. 2 (2017), s. 148-155
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27684070 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523133145 $b ABA008
999    __
$a ok $b bmc $g 1300642 $s 1013858
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 98 $c 2 $d 148-155 $e 20160930 $i 1423-0399 $m Urologia internationalis $n Urol Int $x MED00004616
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...